BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock
$9,34
Harga · Agu 25, 2026
Fundamental per Agu 11, 2026
Rentang 52M
$7–$15
30% of range
Peringkat Analis
BUY
17 analysts
Target Harga
$25
+167% upside
P/E (TTM)
-2.2
ROE
-146.2%
Margin Laba Bersih
—
BBOT Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$9.34
Kapitalisasi Pasar
$747M
P/E (TTM)
-2.2
EPS (TTM)
$-4.30
Pendapatan (TTM)
—
Imbal Hasil Dividen
—
ROE
-146.2%
D/E Utang/Ekuitas
0.0
Rentang 52M
$7 – $15
BBOT Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Configure
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan & Laba Bersih
—
EPS
$-4.30
2024-12-31
→
2025-12-31
Arus Kas Bebas
$-114M
2025-12-31
→
2025-12-31
Margin
—
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Metrik
Tren 5 Tahun
BBOT
Median Rekan
P/E (TTM)
-2.2
70.4
P/B
1.8
2.2
EV / EBITDA
-2.2
—
Price / FCF (Harga / FCF)
-6.5
—
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Metrik
Tren 5 Tahun
BBOT
Median Rekan
ROA
-43.8%
-35.6%
ROE
-146.2%
-37.4%
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Metrik
Tren 5 Tahun
BBOT
Median Rekan
Debt / Equity (Utang / Ekuitas)
0.0
—
Current Ratio (Rasio Lancar)
12.3
7.1
Quick Ratio (Rasio Cepat)
12.1
—
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Metrik
Tren 5 Tahun
BBOT
Median Rekan
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Metrik
Tren 5 Tahun
BBOT
Median Rekan
BBOT Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
BELI
17 analis
- Beli Kuat 6 35,3%
- Beli 10 58,8%
- Tahan 1 5,9%
- Jual 0 0,0%
- Jual Kuat 0 0,0%
Target Harga 12 Bulan
10 analis · 2026-08-22
Median
$23.50
← Di bawah semua target
$9.34
Rendah
$18.00
Tinggi
$39.00
Target median
$23.50
+151,7%
Target rata-rata
$24.90
+166,7%
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-0.20%
| Periode | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|
| 31 Maret 2026 | $-0.53 | $-0.54 | 0.01% |
| 31 Des. 2025 | $-0.49 | $-0.53 | 0.04% |
| 30 Sep. 2025 | $-1.03 | $-0.40 | -0.63% |
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| BBOT | $1.00B | -2.9 | — | — | -146.2% | — |
| STTK | $231M | -5.2 | -82.5% | -4880.9% | -70.0% | — |
| NVCT | $194M | -5.7 | — | — | -149.9% | — |
| MNPR | — | — | — | — | — | — |
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | — |
| ALLO | $314M | -1.6 | -76.8% | — | -59.9% | — |
| CTMX | $725M | — | -44.8% | -22.8% | -15.9% | — |
| TECX | $391M | -5.2 | — | — | -27.7% | — |
| IRWD | $550M | 22.5 | -15.7% | 8.1% | -8.5% | — |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi 13
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| R&D Expense | $121M | $73M | · | |
| SG&A Expense | $25M | $8M | $41.7K | |
| Operating Expenses | $146M | $81M | · | |
| Operating Income | $-146M | $-81M | $-41.7K | |
| Interest Income | $11M | $6M | · | |
| Other Non-op | $-35.0K | $0 | · | |
| Income Tax | $0 | $0 | · | |
| Net Income | $-134M | $-74M | $-41.7K | |
| EPS (Basic) | $-4.30 | $-5756.41 | · | |
| EPS (Diluted) | $-4.30 | $-5756.41 | · | |
| Shares (Basic) | 31,144,775 | 12,903 | · | |
| Shares (Diluted) | 31,144,775 | 12,903 | · | |
| EBITDA | $-146M | $-584.4K | · |
Neraca 21
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $374M | $31M | $0 | |
| Short-term Investments | $52M | $125M | · | |
| Prepaid Expense | $7M | $3M | · | |
| Current Assets | $432M | $159M | · | |
| PP&E (Net) | $956.0K | $490.0K | · | |
| Other Non-current Assets | $13M | $5M | · | |
| Total Assets | $448M | $164M | $332.9K | |
| Accounts Payable | $1M | $3M | · | |
| Accrued Liabilities | · | $119.7K | $15.0K | |
| Short-term Debt | $534.0K | $483.0K | $70.1K | |
| Current Liabilities | $35M | $20M | $396.5K | |
| Capital Leases | $2M | $0 | · | |
| Total Liabilities | $37M | $20M | $396.5K | |
| Total Debt | $534.0K | · | · | |
| Common Stock | $8.0K | $0 | · | |
| Paid-in Capital | $768M | $44M | $24.5K | |
| Retained Earnings | $-357M | $-223M | $-88.6K | |
| AOCI | $16.0K | $348.0K | · | |
| Stockholders' Equity | $411M | $-179M | $-116M | |
| Liabilities + Equity | $448M | $164M | $332.9K | |
| Shares Outstanding | 79,991,768 | 28,415 | · |
Arus Kas 9
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $6M | $4M | · | |
| Deferred Tax | $0 | $0 | · | |
| Operating Cash Flow | $-114M | $-55M | · | |
| CapEx | $606.0K | $49.0K | · | |
| Investing Cash Flow | $73M | $-121M | · | |
| Stock Issued | $112M | · | · | |
| Net Stock Activity | $112M | · | · | |
| Financing Cash Flow | $383M | $206M | · | |
| Free Cash Flow | $-114M | · | · |
Profitabilitas 2
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| ROA | -43.8% | 7.8% | · | |
| ROE | -146.2% | -9.3% | · |
Likuiditas & Solvabilitas 3
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 12.3 | 10.4 | · | |
| Quick Ratio | 12.1 | 9.1 | · | |
| Debt / Equity | 0.0 | · | · |
Valuasi (TTM) 11
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Net Income TTM | $-134M | $-74M | · | |
| Market Cap | $1.00B | · | · | |
| Enterprise Value | $577M | · | · | |
| P/E | -2.9 | -0.0 | · | |
| P/B | 2.4 | · | · | |
| P / Tangible Book | 2.4 | · | · | |
| P / Cash Flow | -8.8 | · | · | |
| P / FCF | -8.7 | · | · | |
| EV / EBITDA | -4.0 | · | · | |
| EV / FCF | -5.0 | · | · | |
| Earnings Yield | -34.4% | -54823.0% | · |
Laporan Laba Rugi 13
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $49M | $40M | $38M | $35M | $27M | $21M | $20M | $18M | · | · | |
| SG&A Expense | $11M | $6M | $7M | $14M | $3M | $3M | $6M | $2M | $152.3K | $66.7K | |
| Operating Expenses | $60M | $46M | $43M | $49M | $30M | $23M | $22M | $20M | · | · | |
| Operating Income | $-60M | $-46M | $-93M | $-49M | $-30M | $-23M | $-61M | $-20M | $-152.3K | $-66.7K | |
| Interest Income | $4M | $4M | $4M | $3M | $2M | $2M | $255.2K | $2M | $2M | $1M | |
| Other Non-op | $-14.0K | $-94.0K | $-4M | $-30.0K | $-8.0K | $-2.0K | $-4M | $0 | $2M | $1M | |
| Income Tax | $0 | · | $0 | $0 | $0 | $0 | $0 | $0 | · | · | |
| Net Income | $-56M | $-42M | $-39M | $-45M | $-28M | $-22M | $-20M | $-17M | $-22M | $-15M | |
| EPS (Basic) | $-705.20 | $-526.11 | $2.19 | $-1.03 | $-566.46 | $-54.23 | $-833.69 | $-1562.18 | · | · | |
| EPS (Diluted) | $-705.20 | $-526.11 | $2.19 | $-1.03 | $-566.46 | $-54.23 | $-833.69 | $-1562.18 | · | · | |
| Shares (Basic) | 80,054,000 | 80,032 | 16,459,785 | 43,491,085 | 50,198,000 | 406,723 | 1,814 | 11,089 | · | · | |
| Shares (Diluted) | 80,054,000 | 80,032 | 16,459,785 | 43,491,085 | 50,198,000 | 406,723 | 1,814 | 11,089 | · | · | |
| EBITDA | $-60M | $-46M | · | $-49M | $-1M | $-2M | · | $-146.9K | $-152.3K | $-66.7K |
Neraca 21
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $54M | $53M | $374M | $409M | $664.2K | $963.1K | $31M | $2M | $2M | $2M | |
| Short-term Investments | $172M | $200M | $52M | $60M | · | · | $125M | · | · | · | |
| Prepaid Expense | $16M | $14M | $7M | $7M | $62.5K | · | $3M | · | $11.3K | $16.3K | |
| Current Assets | $242M | $267M | $432M | $476M | $876.8K | $1M | $159M | $2M | $2M | $2M | |
| PP&E (Net) | $878.0K | $938.0K | $956.0K | $827.0K | · | · | $490.0K | · | · | · | |
| Other Non-current Assets | $13M | $11M | $13M | $5M | · | · | $5M | · | · | · | |
| Total Assets | $377M | $418M | $448M | $485M | $197M | $196M | $164M | $192M | $190M | $188M | |
| Accounts Payable | $7M | $12M | $1M | $4M | $3M | · | $3M | · | · | · | |
| Accrued Liabilities | · | · | · | · | · | $2M | · | $126.7K | $79.1K | $23.3K | |
| Short-term Debt | · | $716.0K | $534.0K | $691.0K | · | · | $483.0K | · | · | · | |
| Current Liabilities | $52M | $43M | $35M | $36M | $3M | $2M | $20M | $126.7K | $79.1K | $23.3K | |
| Capital Leases | $2M | $2M | $2M | $2M | · | · | $0 | · | · | · | |
| Total Liabilities | $54M | $45M | $37M | $38M | $8M | $7M | $20M | $6M | $6M | $6M | |
| Total Debt | · | $716.0K | · | $691.0K | · | · | · | · | · | · | |
| Common Stock | $8.0K | $8.0K | $8.0K | $8.0K | · | · | $0 | · | · | $51 | |
| Paid-in Capital | $779M | $772M | $768M | $764M | · | · | $44M | · | · | · | |
| Retained Earnings | $-455M | $-399M | $-357M | $-318M | $-7M | $-6M | $-223M | $-4M | $-3M | $-3M | |
| AOCI | $-959.0K | $-981.0K | $16.0K | $36.0K | · | · | $348.0K | · | · | · | |
| Stockholders' Equity | $323M | $372M | $411M | $447M | $-7M | $-6M | $-179M | $-4M | $-3M | $-3M | |
| Liabilities + Equity | $377M | $418M | $448M | $485M | $197M | $196M | $164M | $192M | $190M | $188M | |
| Shares Outstanding | 80,115,002 | 80,088,931 | 79,991,768 | 79,196,710 | · | · | 28,415 | · | · | · |
Arus Kas 8
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $7M | $4M | $3M | $3M | $36.0K | $627.0K | $4M | $77.4K | $77.4K | $39.4K | |
| Operating Cash Flow | $-44M | $-36M | $-42M | $-71M | $-298.9K | $-20M | $-15M | $-39M | $-29.1K | $-618.0K | |
| CapEx | $47.0K | $24.0K | $73.0K | $140.0K | $231.0K | $162.0K | $10.0K | · | · | · | |
| Investing Cash Flow | $46M | $-285M | $8M | $41M | $10M | $15M | $26M | $38M | $0 | $-184M | |
| Stock Issued | $0 | $112M | $-9M | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $112M | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $37.0K | $295.0K | $-586.0K | $365M | $19M | $-404.0K | $52.0K | $20M | $0 | $186M | |
| Free Cash Flow | · | $-36M | · | · | · | · | · | · | · | · |
Profitabilitas 2
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -19.7% | -13.7% | · | -13.2% | 0.47% | -0.25% | · | 2.4% | 2.3% | 1.2% | |
| ROE | -35.8% | -23.0% | · | -20.2% | -17.2% | 10.4% | · | -132.7% | -131.2% | -68.3% |
Likuiditas & Solvabilitas 3
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.7 | 6.2 | · | 13.3 | 0.3 | 0.7 | · | 16.1 | 26.2 | 90.4 | |
| Quick Ratio | 4.4 | 5.8 | · | 13.1 | 0.3 | 0.5 | · | 14.1 | 22.9 | 79.0 | |
| Debt / Equity | · | 0.0 | · | 0.0 | · | · | · | · | · | · |
Valuasi (TTM) 11
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-172M | $-137M | · | $-113M | $-90M | $-77M | · | · | · | · | |
| Market Cap | $610M | $717M | · | $917M | · | · | · | · | · | · | |
| Enterprise Value | · | $465M | · | $450M | · | · | · | · | · | · | |
| P/E | -0.0 | · | · | · | · | · | · | · | · | · | |
| P/B | 1.9 | 1.9 | · | 2.1 | · | · | · | · | · | · | |
| P / Tangible Book | 1.9 | 1.9 | · | 2.1 | · | · | · | · | · | · | |
| P / Cash Flow | · | -20.0 | · | · | · | · | · | · | · | · | |
| P / FCF | · | -19.9 | · | · | · | · | · | · | · | · | |
| EV / EBITDA | · | -10.1 | · | -9.1 | · | · | · | · | · | · | |
| EV / FCF | · | -12.9 | · | · | · | · | · | · | · | · | |
| Earnings Yield | -23606.3% | · | · | · | · | · | · | · | · | · |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Laporan Laba Rugi
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Laba Bersih | $-134M | $-74M | $-41.7K |
| EPS Dilusian | $-4.30 | $-5756.41 | — |
Neraca
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Utang / Ekuitas | 0.0 | — | — |
| Rasio Lancar | 12.3 | 10.4 | — |
| Rasio Cepat | 12.1 | 9.1 | — |
Arus Kas
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Arus Kas Bebas | $-114M | — | — |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
📊
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Pemilik institusional (13F) 65 pengaju · $429.4M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 17 (-4 vs Kuartal sebelumnya) | 18 (+11 vs Kuartal sebelumnya) | 18 (-1 vs Kuartal sebelumnya) | 14 (+3 vs Kuartal sebelumnya) | +1.5M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| Cormorant Asset Management, LP | $136.234.886 | 17.878.594 | 31,73% | Saham |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $37.227.099 | 4.885.446 | 8,67% | Saham |
| Omega Fund Management, LLC | $25.067.217 | 3.289.661 | 5,84% | Saham |
| Alphabet Inc. | $21.512.220 | 2.823.126 | 5,01% | Saham |
| EcoR1 Capital, LLC | $21.512.220 | 2.823.126 | 5,01% | Saham |
| WELLINGTON MANAGEMENT GROUP LLP | $21.254.481 | 2.789.302 | 4,95% | Saham |
| ENAVATE SCIENCES GP, LLC | $20.017.329 | 2.626.946 | 4,66% | Saham |
| CITADEL ADVISORS LLC | $19.269.166 | 2.528.762 | 4,49% | Saham |
| NOVO HOLDINGS A/S | $17.145.000 | 2.250.000 | 3,99% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $15.283.045 | 2.005.649 | 3,56% | Saham |
| Laurion Capital Management LP | $15.260.582 | 2.002.701 | 3,55% | Saham |
| ARMISTICE CAPITAL, LLC | $13.441.680 | 1.764.000 | 3,13% | Saham |
| STATE STREET CORP | $7.898.656 | 1.036.569 | 1,84% | Saham |
| Aisling Capital Management LP | $7.757.297 | 1.018.018 | 1,81% | Saham |
| Opaleye Management Inc. | $5.334.000 | 700.000 | 1,24% | Saham |
| Granahan Investment Management, LLC | $4.255.968 | 558.526 | 0,99% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $3.918.497 | 513.932 | 0,91% | Saham |
| SPHERA FUNDS MANAGEMENT LTD. | $3.512.706 | 460.985 | 0,82% | Saham |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $3.048.000 | 400.000 | 0,71% | Saham |
| ROYCE & ASSOCIATES LP | $2.933.250 | 384.941 | 0,68% | Saham |
| Catalio Capital Management, LP | $2.426.261 | 318.407 | 0,57% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $2.221.398 | 291.522 | 0,52% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2.183.267 | 286.518 | 0,51% | Saham |
| Casdin Capital, LLC | $2.151.217 | 282.312 | 0,50% | Saham |
| Ensign Peak Advisors, Inc | $2.084.299 | 273.530 | 0,49% | Saham |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $1.872.418 | 244.441 | 0,44% | Saham |
| FMR LLC | $1.833.235 | 240.582 | 0,43% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $1.456.578 | 191.152 | 0,34% | Saham |
| NORTHERN TRUST CORP | $1.230.493 | 161.482 | 0,29% | Saham |
| Sio Capital Management, LLC | $995.385 | 130.628 | 0,23% | Saham |
| UBS Group AG | $873.671 | 114.655 | 0,20% | Saham |
| MILLENNIUM MANAGEMENT LLC | $803.758 | 105.480 | 0,19% | Saham |
| GOLDMAN SACHS GROUP INC | $777.888 | 102.085 | 0,18% | Saham |
| MOORE CAPITAL MANAGEMENT, LP | $762.000 | 100.000 | 0,18% | Saham |
| Brevan Howard Capital Management LP | $690.714 | 88.895 | 0,16% | Saham |
| Palumbo Wealth Management LLC | $652.455 | 85.624 | 0,15% | Saham |
| BlackRock, Inc. | $566.867 | 74.392 | 0,13% | Saham |
| Jump Financial, LLC | $472.440 | 62.000 | 0,11% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $446.532 | 58.600 | 0,10% | Saham |
| BANK OF AMERICA CORP /DE/ | $409.072 | 53.684 | 0,10% | Saham |
| Avidity Partners Management LP | $334.160 | 43.853 | 0,08% | Saham |
| TD Asset Management Inc | $325.603 | 42.730 | 0,08% | Saham |
| Virtus Investment Advisers, LLC | $321.716 | 42.220 | 0,07% | Saham |
| VANGUARD GROUP INC | $227.401 | 18.163 | 0,05% | Saham |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $213.238 | 27.984 | 0,05% | Saham |
| TWO SIGMA INVESTMENTS, LP | $201.816 | 26.485 | 0,05% | Saham |
| Rafferty Asset Management, LLC | $172.258 | 22.606 | 0,04% | Saham |
| CITIGROUP INC | $151.425 | 19.872 | 0,04% | Saham |
| Squarepoint Ops LLC | $149.824 | 19.662 | 0,03% | Saham |
| Vanguard Global Advisers, LLC | $138.402 | 18.163 | 0,03% | Saham |
| Schonfeld Strategic Advisors LLC | $87.659 | 11.504 | 0,02% | Saham |
| PROFUND ADVISORS LLC | $83.828 | 11.001 | 0,02% | Saham |
| AXQ CAPITAL, LP | $81.747 | 10.728 | 0,02% | Saham |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $20.115 | 2.626 | 0,00% | Saham |
| BARCLAYS PLC | $15.827 | 2.077 | 0,00% | Saham |
| Tower Research Capital LLC (TRC) | $12.924 | 1.696 | 0,00% | Saham |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $10.287 | 1.350 | 0,00% | Saham |
| Rockefeller Capital Management L.P. | $7.620 | 1.000 | 0,00% | Saham |
| Integrated Wealth Concepts LLC | $3.330 | 437 | 0,00% | Saham |
| MORGAN STANLEY | $2.286 | 300 | 0,00% | Saham |
| WELLS FARGO & COMPANY/MN | $2.286 | 300 | 0,00% | Saham |
| PRICE T ROWE ASSOCIATES INC /MD/ | $2.286 | 300.000 | 0,00% | Saham |
| Quarry LP | $1.501 | 197 | 0,00% | Saham |
| Caitong International Asset Management Co., Ltd | $282 | 37 | 0,00% | Saham |
| Pacer Advisors, Inc. | $3 | 378 | 0,00% | Saham |
Orang dalam perusahaan 17 orang dalam · 5 pejabat · 10 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Pedro Beltran | President and CEO | 1 Juli 2026 F | 44.576 | 0 | 0 | $0 |
| Eli M. Wallace | Chief Executive Officer | 1 Jan. 2026 A | — | 0 | 0 | $0 |
| Idan Elmelech | COO & Principal Financial Ofcr | 1 Juli 2026 F | 14.495 | 0 | 0 | $0 |
| Yong Ben | Chief Med & Dev Officer | 1 Juli 2026 F | 44.576 | 0 | 0 | $0 |
| Marc Cobo | Principal Accounting Officer | 1 Juli 2026 F | 5.306 | 0 | 0 | $0 |
| Chen Bihua | Direktur | 1 Juli 2026 J | 6.083.221 | 0 | 0 | $0 |
| Peter F Lebowitz | Direktur | 16 Juni 2026 A | — | 0 | 0 | $0 |
| Raymond J. Kelleher | Direktur | 16 Juni 2026 A | — | 0 | 0 | $0 |
| Praveen P. Tipirneni | Direktur | 16 Juni 2026 A | — | 0 | 0 | $0 |
| Neil Kumar | Direktur | 16 Juni 2026 A | — | 0 | 0 | $0 |
| Jake Bauer | Direktur | 16 Juni 2026 A | — | 0 | 0 | $0 |
| Frank Mccormick | Direktur | 16 Juni 2026 A | — | 0 | 0 | $0 |
| Helix Holdings II LLC | Direktur | 8 Feb. 2025 J | 509.000 | 0 | 0 | $0 |
| Uneek Mehra | — | 1 April 2026 F | 22.806 | 0 | 0 | $0 |
| Albert A Holman III | — | 11 Agu 2025 M | 30.000 | 0 | 0 | $0 |
| Mark C. Mckenna | — | 11 Agu 2025 M | 30.000 | 0 | 0 | $0 |
| John P. Schmid | — | 11 Agu 2025 M | 30.000 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Aktivis & pemilik 5%+ 3 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Bihua Chen, Cormorant Private Healthcare Fund III, LP, Cormorant Private Healthcare GP III, LLC, Cormorant Private Healthcare Fund V, LP, Cormorant Private Healthcare GP V, LLC, Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Helix Holdings II LLC | 6 Juli 2026 | 22,32% | Amandemen | — | SEC |
| BridgeBio Pharma LLC, BridgeBio Pharma, Inc. | 18 Agu 2025 | 17,50% | Pengajuan awal | Kampanye dewan | SEC |
| Helix Holdings II LLC, Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Bihua Chen ×3 pengajuan | 13 Agu 2025 | 22,60% | Amandemen | Investasi pasif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Kepemilikan ETF Dimiliki oleh 6 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| CANC · Tema ETF Trust | 0,48% | 93.339 NS | 31 Mei 2026 | N-PORT |
| IBB · iShares Trust | 0,03% | 322.024 SH | 21 Agu 2026 | Harian |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 227.258 NS | 31 Mei 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 27.500 NS | 31 Mei 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 549.132 SH | 19 Agu 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.422.900 SH | 19 Agu 2026 | Harian |